medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2018-13-174-178medsovet-2625Research ArticleПрактикаPracticeЛечение дисменореи в амбулаторных условиях: современные возможностиManagement of dismenorea in outpatient settings: modern opportunitiesКачалинаО. В.KachalinaO. V.

д.м.н., доцент кафедры акушерства и гинекологии,

Нижний Новгород

MD,

Nizhny Novgorod

КореньковаА. А.KorenkovaA. A.

аспирант кафедры акушерства и гинекологии,

Нижний Новгород

Nizhny Novgorod

ФДПО «Приволжский исследовательский медицинский университет» Минздрава РоссииРоссияFaculty of Additional Professional Education “Privolzhskiy Research Medical University” of the Ministry of Health of RussiaRussian Federation201825092018013174178Copyright © Качалина О.В., Коренькова А.А., 20182018Качалина О.В., Коренькова А.А.Kachalina O.V., Korenkova A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/2625

В статье рассматриваются факторы формирования и современные методы лечения дисменореи. Консервативное лечение предусматривает применение комбинированных гормональных контрацептивов, физиотерапевтических процедур, витаминов и симптоматических средств. Авторами отмечается значимость препарата Нимесил® в первой линии терапии первичной дисменореи синдрома наравне с комбинированными гормональными контрацептивами и симптоматическими средствами. Применение данного препарата характеризуется быстрым началом действия, выраженным обезболивающим эффектом и хорошей переносимостью.

The article considers the causes for the development and modern methods of managing dysmenorrhea. The conservative therapy includes the use of combined hormonal contraceptives, physiotherapy procedures, vitamins and symptomatic drugs. The authors stress the significance of Nimesil® in the first-line therapy of primary dysmenorrhea of the syndrome along with the combined hormonal contraceptives and symptomatic agents. The use of this drug is characterized by rapid onset of effect, strong analgesic effect and good tolerability.

дисменореяэндометриозНимесил®DysmenorrheaendometriosisNimesil®ReferencesУнанян А.Л. и соавт. Современные представления об этиопатогенезе, клинике и терапии дисменореи. Медицинский совет, 2017, 2: 112- 115.Unanyan AL et al. Modern view of etiopathogenesis, clinic and therapy of dysmenorrhea. Meditsinsky Sovet, 2017, 2: 112-115.Серов В.Н., Прилепская В.Н., Овсянникова Т.В. Гинекологическая эндокринология. 4-е изд. М.: МЕДпресс-информ, 2012. 528 с.Serov VN, Prilepskaya VN, Ovsyannikova ТV. Gynecological endocrinology. 4th ed. М.: MEDPRESS-INFORM, 2012. 528 p.Pitangui AC, Gomes MR, Lima AS, Schwingel PA,Albuquerque AP, de Araujo RC. Menstruation disturbances: prevalence, characteristics, and effects on the activities of daily living among adolescent girls from Brazil. J Pediatr Adolesc Gynecol, 2013, 26: 148–152.Pitangui AC, Gomes MR, Lima AS, Schwingel PA,Albuquerque AP, de Araujo RC. Menstruation disturbances: prevalence, characteristics, and effects on the activities of daily living among adolescent girls from Brazil. J Pediatr Adolesc Gynecol, 2013, 26: 148–152.Ayan M, Sogut E, Tas U, Erdemir F, Sahin M, Suren M, Kaya Z, Demirturk F. Pain levels associated with renal colic and primary dysmenorrhea: a prospective controlled study with objective and subjective outcomes. Arch Gynecol Obstet, 2012, 286: 403–409.Ayan M, Sogut E, Tas U, Erdemir F, Sahin M, Suren M, Kaya Z, Demirturk F. Pain levels associated with renal colic and primary dysmenorrhea: a prospective controlled study with objective and subjective outcomes. Arch Gynecol Obstet, 2012, 286: 403–409.Banikarim C, Chaco MR, Kelder SH. Prevalence and impact of dysmenorrhea on Hispanic female adolescents. Arch Pediatr Adolesc Med, 2000, 154: 1226-9.Banikarim C, Chaco MR, Kelder SH. Prevalence and impact of dysmenorrhea on Hispanic female adolescents. Arch Pediatr Adolesc Med, 2000, 154: 1226-9.Strinic T, Bukovic D, Pavelic L, Fajdic J, Herman I, Stipic I, et al. Anthropological and clinic characteristic in adolescent women with dysmenorrhea. Coll Antropol, 2003, 27: 707-11.Strinic T, Bukovic D, Pavelic L, Fajdic J, Herman I, Stipic I, et al. Anthropological and clinic characteristic in adolescent women with dysmenorrhea. Coll Antropol, 2003, 27: 707-11.Унанян А.Л. и соавт. Дисменорея, аденомиоз, эндометриоз, опухолевый процесс: причинноследственные связи. 2017, 11: 186-188.Unanyan AL, et al. Dysmenorrhea, adenomyosis, endometriosis, tumor process: cause-effect relationships. 2017, 11: 186-188.Руководство по амбулаторно-поликлинической помощи в акушерстве и гинекологии. Под ред. В.Е. Радзинского, М.: ГЭОТАР-Медиа, 2014. 944 с.A guide to outpatient care in obstetrics and gynecology. Edited by Radzinsky VE, Moscow: GEOTAR-Media, 2014. 944 p.Pejčić A, Janković S. Risk factors for dysmenorrhea among young adult female university students. Ann Ist Super Sanita, 2016 Jan-Mar, 52(1): 98-103.Pejčić A, Janković S. Risk factors for dysmenorrhea among young adult female university students. Ann Ist Super Sanita, 2016 Jan-Mar, 52(1): 98-103.Altunyurt S, Gol M, Altunyurt S, Sezer O, Demir N. Primary dysmenorrhea and uterine blood flow: a color Doppler study. J Reprod Med, 2005, 50: 251-5.Altunyurt S, Gol M, Altunyurt S, Sezer O, Demir N. Primary dysmenorrhea and uterine blood flow: a color Doppler study. J Reprod Med, 2005, 50: 251-5.Lopez LM, Grimpes DA, Gallo MF, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database of Systematic Reviews, 2010, Issue 3, Art No.: CD003552.Lopez LM, Grimpes DA, Gallo MF, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database of Systematic Reviews, 2010, Issue 3, Art No.: CD003552.Мозес В.Г., Ожогина Е.В. Первичная дисменорея, пособие для врачей, 2012.Moses VG, Ozhogina EV. Primary dysmenorrhoea, a guide for doctors, 2012.Proctor ML, Roperts H, Farquar CM. Combinated oral contraceptive pill as treatment for primary dysmenorrhea. Cochrane Database of Systematic Reviews, 2001, 3: CD002120.Proctor ML, Roperts H, Farquar CM. Combinated oral contraceptive pill as treatment for primary dysmenorrhea. Cochrane Database of Systematic Reviews, 2001, 3: CD002120.Клинические рекомендации. Акушерство и гинекология. Под ред. Г.М. Савельевой, В.Н. Серова, Г.Т. Сухих. 2009.Clinical guidelines. Obstetrics and gynecology. Edited by Savelieva GM, Serova VN, Sukhikh GT. 2009.Sulak PJ, Kuehl TJ, Ortiz M, Shull BL. Acceptance of altering the standart 21 day/7 day oral contraceptive ragimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynicol, 2002, 186: 1142-9.Sulak PJ, Kuehl TJ, Ortiz M, Shull BL. Acceptance of altering the standart 21 day/7 day oral contraceptive ragimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynicol, 2002, 186: 1142-9.Akerlund M, Forsling M, Kindahl H, Stimulator of vasopressin release in women with primary dysmenorrhea and after oral contraceptive tritment. Br J Obstet Gynicol, 1992, 99: 680-4.Akerlund M, Forsling M, Kindahl H, Stimulator of vasopressin release in women with primary dysmenorrhea and after oral contraceptive tritment. Br J Obstet Gynicol, 1992, 99: 680-4.Yusoff Dawood M. Primari Dismenorrhea. Advances in Pathogenesis and Management. ACOG, 2006 August, 108(2).Yusoff Dawood M. Primari Dismenorrhea. Advances in Pathogenesis and Management. ACOG, 2006 August, 108(2).Wiegratz I, Kuhl H. Прием оральных контрацептивов в режиме длинного цикла. Drugs, 2004, 64: 2447-2462.Wiegratz I, Kuhl H. Прием оральных контрацептивов в режиме длинного цикла. Drugs, 2004, 64: 2447-2462.Ulmsten U. Uterine activity and blood flow in normal and dysmenorrheic women. Baltimore (MD), Urban and Schwarzenberg, 1985: 103-124.Ulmsten U. Uterine activity and blood flow in normal and dysmenorrheic women. Baltimore (MD), Urban and Schwarzenberg, 1985: 103-124.Каратаев А.Е. и соавт. Клинические рекомендации: рациональное применение нестероидных противовоспалительных препаратов (НПВП) в клинической практике. Современная ревматология, 2015, 9(1): 4-23. https://doi. org/10.14412/1996-7012-2015-1-4-23.Karataev AE, et al. Clinical guidelines: rational use of non-steroidal anti-inflammatory drugs (NSAIDs) in clinical practice. Sovremennaya Revmatologiya, 2015, 9 (1): 4-23. https://doi. org/10.14412/1996-7012-2015-1-4-23.Dequeker J, Hawkey C, Kahan A. et al. Improvement in gastrointestinal tolerabilitiof the selective cyclooxygenase inhibitors, meloxicam, compared with peroxicam; results of the safety and efficacy largescale evaluation of COX-ihibiting therapies thrial in osteoarthritis. Br J Rheumatol, 1998, 37: 946-51.Dequeker J, Hawkey C, Kahan A. et al. Improvement in gastrointestinal tolerabilitiof the selective cyclooxygenase inhibitors, meloxicam, compared with peroxicam; results of the safety and efficacy largescale evaluation of COX-ihibiting therapies thrial in osteoarthritis. Br J Rheumatol, 1998, 37: 946-51.Herel Z. A contemporary approach to dysmenorrhea in adolescents. Paediatr drugs, 2002, 4: 797-805.Herel Z. A contemporary approach to dysmenorrhea in adolescents. Paediatr drugs, 2002, 4: 797-805.Taha AS, Anderson VJ, Prasad R et al. Upper gastrointestinal bleeding and the changing use of COX-2 nonsteriodal anti-inflammatory drugs and low-dose aspirin. Aliment Pharmacol Ther, 2007, 26: 1171-8.Taha AS, Anderson VJ, Prasad R et al. Upper gastrointestinal bleeding and the changing use of COX-2 nonsteriodal anti-inflammatory drugs and low-dose aspirin. Aliment Pharmacol Ther, 2007, 26: 1171-8.Gislason GH, Rasmussen JN, Abildstorm SZ. Increased Mortality and cardiovascular Mortality Associated With Use of nonsteroidal Anti-inflammatory Drugs in Chronic Heart Failure. Arch intern med, 2009, 169(2): 141-9.Gislason GH, Rasmussen JN, Abildstorm SZ. Increased Mortality and cardiovascular Mortality Associated With Use of nonsteroidal Anti-inflammatory Drugs in Chronic Heart Failure. Arch intern med, 2009, 169(2): 141-9.Davis R, Brogden RN. Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs, 1994, 48: 431–54.Davis R, Brogden RN. Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs, 1994, 48: 431–54.Rainsford KD. Mode of action, uses and sideeffects of anti-rheumatic drugs. In: Rainsford KD, ed. Advances in anti-rheumatic therapy. Boca Raton, FL: CRC Press, 1996: 59–111.Rainsford KD. Mode of action, uses and sideeffects of anti-rheumatic drugs. In: Rainsford KD, ed. Advances in anti-rheumatic therapy. Boca Raton, FL: CRC Press, 1996: 59–111.Воробьева О.В. Взаимосвязь спектра безопасности нимесулида и особенностей его механизма действия, химической структуры и фармакокинетики. Consilium Medicum, 2010, 2: 5–8.Vorobyeva OV. Interrelation of the safety spectrum of nimesulide and features of its action mechanism, chemical structure and pharmacokinetics. Consilium Medicum, 2010, 2: 5-8.Аlessandrini А, Ваllаriп Е, Ваstianon А, Мigliаvасса С. Clin Ther, 1986, 118(3): 177-82.Аlessandrini А, Ваllаriп Е, Ваstianon А, Мigliаvасса С. Clin Ther, 1986, 118(3): 177-82.Transdermal glyceril trinitrate in the management of primary dysmenorrhea. Int J Ginaecol Obstet, 2000, 69: 113-8.Transdermal glyceril trinitrate in the management of primary dysmenorrhea. Int J Ginaecol Obstet, 2000, 69: 113-8.Wilson ML, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhea Coch rane Review. The Cochrane Library, 2001, Issue 3.Wilson ML, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhea Coch rane Review. The Cochrane Library, 2001, Issue 3.Ulmsten U. Calcium Dlocade as a rapid pharmacological to evaluate primary dysmenorrhea. Gynaecol Obstet invest, 1985, 20: 78-83.Ulmsten U. Calcium Dlocade as a rapid pharmacological to evaluate primary dysmenorrhea. Gynaecol Obstet invest, 1985, 20: 78-83.Gokhale LB. Curative treatment of primary dysmenorrhea. Indian jornal of medical Research, 1996, 103: 227-231.Gokhale LB. Curative treatment of primary dysmenorrhea. Indian jornal of medical Research, 1996, 103: 227-231.Ziaei S, Zakeri M, Kazemnejad A. A randomized controlled trial of vitamin E in the treatment of primary dysmenorrhea. BJOG, 2005, 112: 466-9.Ziaei S, Zakeri M, Kazemnejad A. A randomized controlled trial of vitamin E in the treatment of primary dysmenorrhea. BJOG, 2005, 112: 466-9.Eccleston C, Williams. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database of Systematic Reviews, 2009, Issue 2: CD007407.Eccleston C, Williams. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database of Systematic Reviews, 2009, Issue 2: CD007407.Proctor ML, Hing W, Johnson TC. Spinal manipulation for primary and secondary dysmenorrhoea (Coch rane Review). The Cochrane Library, 2004, Issue 3.Proctor ML, Hing W, Johnson TC. Spinal manipulation for primary and secondary dysmenorrhoea (Coch rane Review). The Cochrane Library, 2004, Issue 3.Pallavi, Latthe. Factors predisposing women to chronic pelvic pain: systematic review. BMJ, 2006, 332: 749-755.Pallavi, Latthe. Factors predisposing women to chronic pelvic pain: systematic review. BMJ, 2006, 332: 749-755.Pediatric and Adolescent Gynecology: EvidenceBased Clinical Practice (Endocrine Development, V. 7). Ed. Charles Sultan. Switzerland: S. KargerPub, 2004. 270 р.Pediatric and Adolescent Gynecology: EvidenceBased Clinical Practice (Endocrine Development, V. 7). Ed. Charles Sultan. Switzerland: S. KargerPub, 2004. 270 р.Morrow C, Naumburg EH. Dysmenorrhea. Prim Care, 2009, 36(1): 19–32.Morrow C, Naumburg EH. Dysmenorrhea. Prim Care, 2009, 36(1): 19–32.Стругацкий В.М., Маланова Т.Б., Арсланян К.Н. Физиотерапия в практике акушера-гинеколога: Клинические аспекты и рецептура. М.: МЕДпресс-информ, 2008. 272 с.Strugatsky VM, Malanova TB, Arslanyan KN. Physiotherapy in the practice of obstetrician-gynecologist: Clinical aspects and formulation. Moscow: MEDPRESS-INFORM, 2008. 272 pp.Proctor ML, Smith CA. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhea. In: The Cochrane Librari, Issule 1, 2002. Oxford: update Software.Proctor ML, Smith CA. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhea. In: The Cochrane Librari, Issule 1, 2002. Oxford: update Software.Qu F, Zhou J, Ma B. The effect of chinese herbs on the cytokines of rats with endometriosis. J Altern Complement Med, 2005, 11: 627-630.Qu F, Zhou J, Ma B. The effect of chinese herbs on the cytokines of rats with endometriosis. J Altern Complement Med, 2005, 11: 627-630.Yu S, Yang J, Yang M, Gao Y, Chen J, Ren Y, Zhang L, Chen L, Liang F, Hu Y. Application of acuoints and meridians for the treatment of primary dysmenorrhea: a data mining-based literature study. Evid Based Complement Alternat Med, 2015: 752194.Yu S, Yang J, Yang M, Gao Y, Chen J, Ren Y, Zhang L, Chen L, Liang F, Hu Y. Application of acuoints and meridians for the treatment of primary dysmenorrhea: a data mining-based literature study. Evid Based Complement Alternat Med, 2015: 752194.Ortiz MI, Cortés-Márquez SK, Romero-Quezada LC, Murguía-Cánovas G, Jaramillo Díaz AP. Effect of a physiotherapy program in women with primary dysmenorrhea. Eur J Obstet Gynecol Reprod Biol, 2015 Nov, 194: 24-9.Ortiz MI, Cortés-Márquez SK, Romero-Quezada LC, Murguía-Cánovas G, Jaramillo Díaz AP. Effect of a physiotherapy program in women with primary dysmenorrhea. Eur J Obstet Gynecol Reprod Biol, 2015 Nov, 194: 24-9.

The authors declare that there are no conflicts of interest present.